Helius Therapeutics Launches Two GMP-Certified Medicinal Cannabis Products in New Zealand

Dec.30.2022
Helius Therapeutics Launches Two GMP-Certified Medicinal Cannabis Products in New Zealand
New Zealand company Helius is producing four GMP-certified medicinal cannabis products and plans to export to Europe in 2023.

In New Zealand, two new medicinal cannabis products have been confirmed to meet sales quality standards. Earlier, Helius became the first New Zealand company to receive GMP certification, producing tetrahydrocannabinol extracts and manufacturing medicines containing tetrahydrocannabinol.


Carmen Doran, Chief Executive of Helius Therapeutics, has expressed delight in bringing more medicinal cannabis products that are grown and manufactured in New Zealand to patients. The company will launch two new drugs in the New Zealand market, bringing the total number of new drugs to be launched by Helius in 2022 to four. This means that the company's product portfolio now comprises six products, according to an email sent to Vapor Voice.


In mid-December, we were able to announce GACP certification, and since then, we have also obtained GMP certification for an additional four processes in our East Auckland factory. This progress demonstrates the collaborative culture being established by the Helius team," she said.


Helius is the only company in New Zealand that has received GMP certification for the extraction and manufacturing of CBD and THC drugs. Moreover, it is now one of two companies in the country that has six products that have been verified to meet the minimum quality standards (the other being Nubu Pharma).


The latest product will be exported to Helius clients in Europe in 2023.


Products containing THC have attracted great interest internationally, with GMP-manufactured products gaining widespread attention worldwide as the medical market continues to grow. "We are particularly interested in a balanced full-spectrum medicinal cannabis formula," said Doran.


With the launch of these products, New Zealand patients now have access to a range of locally manufactured oral liquid products. They will no longer have to rely on imported products that may experience supply delays throughout 2022 and may come at a much higher cost.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Illegal Vape Seizure in Palmerston: Australian Police Crackdown
Illegal Vape Seizure in Palmerston: Australian Police Crackdown
Northern Territory Police seize illegal substances including cannabis and 2335 nicotine e-cigarettes in Palmerston area. Two suspects identified.
Feb.03 by 2FIRSTS.ai
UK MPs Raise Concerns over Youth Vaping Risks
UK MPs Raise Concerns over Youth Vaping Risks
Carla Lockhart of the DUP warns of e-cigarette dangers to children, while Andrew Gwynne (Labour) questions the government's policies on tobacco.
Nov.29 by 2FIRSTS.ai
Dutch Court Upholds Flavored E-Cigarette Ban, Rejects British American Tobacco's Appeal
Dutch Court Upholds Flavored E-Cigarette Ban, Rejects British American Tobacco's Appeal
Dutch court upholds e-cigarette flavor ban, dismisses lawsuit from British American Tobacco (BAT) and affiliates. The court ruled that, although the ban may impact the free movement of goods, it is appropriate and necessary for public health reasons.
Nov.07 by 2FIRSTS.ai
FDA bans flavored e-cigarettes, STAT investigates non-compliance
FDA bans flavored e-cigarettes, STAT investigates non-compliance
FDA bans flavored e-cigarettes & investigates manufacturers violating regulations, while some brands continue to ignore warnings.
Sep.21 by 2FIRSTS.ai
Yinghe Technology: Sikary Has No Plan for Nicotine Pouch, Medical or Health Vaporization Products
Yinghe Technology: Sikary Has No Plan for Nicotine Pouch, Medical or Health Vaporization Products
Investors inquire about Yinghe Technology's subsidiary, Sikary, potential plans to enter European nicotine pouch market, company responds negatively.
Business
May.24 by 2FIRSTS.ai
Russia Submits Law on Unauthorized Tobacco Production and Sales
Russia Submits Law on Unauthorized Tobacco Production and Sales
Russia introduces fines and imprisonment for unauthorized tobacco production, supply and purchase, with maximum penalty of 100,000 rubles or 3 years in prison.
Mar.13 by 2FIRSTS.ai